Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4380
-0.0143 (-3.16%)
At close: Oct 29, 2026, 4:00 PM EDT
0.4380
0.00 (0.00%)
Pre-market: Oct 30, 2026, 5:59 AM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $8.52 million as of October 29, 2026. It is the 42,315th most valuable company in the world and the 5,693rd biggest in the United States. Its market cap has increased by 35.27% in one year.
Market Cap
8.52M
Enterprise Value
8.04M
1-Year Change
35.27%
Global Rank
Country Rank
#5,693 United States
Category
ChartMarket Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $8.52M, a decrease of -96.58%. That is a compound annual growth rate of -31.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 8.52M | 158.24% |
| Dec 31, 2025 | 3.30M | -68.87% |
| Dec 31, 2024 | 10.60M | 221.21% |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
| Dec 1, 2017 | 249.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 9.59M |
| Purple Biotech | 9.59M |
| IN8bio | 9.46M |
| Palatin Technologies | 9.24M |
| Lisata Therapeutics | 9.19M |
| Moleculin Biotech | 9.02M |
| CalciMedica | 8.95M |
| Theriva Biologics | 8.63M |